Skip to Main Content

Paper Details

Characteristics of Clinical Studies Used for US Food and Drug Administration Supplemental Indication Approvals of Drugs and Biologics, 2017 to 2019.
JAMA Netw Open
16
2021
Author NameAffiliation
Nicholas S Downing
Nilay D ShahRobert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic
Joseph S RossSection of General Medicine and the National Clinical Scholars Program, Yale University School of Medicine
Joseph S RossYale School of Public Health
Joseph S RossCenter for Outcomes Research and Evaluation
  • 1 - 5

Datasets

Release 1.2